loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Avelumab

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Avelumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC
    ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC

    23 May 2024

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/asco-merck-kgaa-pfizers-bavencio-combo-misses-survival-mark-crowded-kidney-cancer-space

    Angus Liu FIERCE PHARMA
    23 May 2024
    Share Share
    Aulos, Merck KGaA Collaborate On Bavencio + AU-007 Combo
    Aulos, Merck KGaA Collaborate On Bavencio + AU-007 Combo

    15 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240515322041/en

    BUSINESSWIRE
    15 May 2024
    Share Share
    Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line
    Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line

    22 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240122986123/en

    BUSINESSWIRE
    22 Jan 2024
    Share Share
    Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
    Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights

    13 Dec 2023

    // REUTERS

    https://www.reuters.com/markets/deals/pfizer-gets-ok-43-bln-seagen-deal-after-donating-cancer-drug-rights-2023-12-12/

    REUTERS
    13 Dec 2023
    Share Share
    EMD Serono's Biologic Bavencio (Avelumab) Receives Approval in the U.S.
    EMD Serono's Biologic Bavencio (Avelumab) Receives Approval in the U.S.

    06 Sep 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761049

    FDA
    06 Sep 2023
    Share Share
    Avelumab Increases PFS Rates in dMMR/MSI Metastatic CRC
    Avelumab Increases PFS Rates in dMMR/MSI Metastatic CRC

    18 Aug 2023

    // ONCLIVE

    https://www.onclive.com/view/avelumab-increases-pfs-rates-in-dmmr-msi-metastatic-crc

    ONCLIVE
    18 Aug 2023
    Share Share